DOT

I’m There: Jonni Salamone

by Pablo Bolanos on November 13, 2017

A team that doesn’t march to the same rhythm will not deliver consistent customer experiences. Jonni Salamone, Director of National Clinical Testing Services, champions the need for individualism, unique work styles, confidence, and above all, team unity. Her leadership inspires her team members to perform beyond the expectations of our clients.

In this month’s edition of our “I’m There” series, Jonni describes what “we’re there when you need us” means to her. Read the full story here.

Employer Solutions shares a commitment to being there when our clients and colleagues need us – at every possible opportunity. Through unique stories from our team, you’ll get a more personal perspective of what that commitment means to them. To learn more about this series, read our introductory post.

For more information about Employer Solutions, visit our website or contact us online.

federal-form.jpgEarlier this year, the Department of Health and Human Services (HHS) revised the Mandatory Guidelines for Federal Workplace Drug Testing Programs. The HHS guideline revisions will lead to the following changes:

  • Expanded Federal urine workplace drug testing to include four Schedule II drugs: hydrocodone, hydromorphone, oxycodone, and oxymorphone
  • Removed MDEA for confirmatory testing
  • Raised the lower pH cutoff from 3 to 4 to identify an adulterated specimen
  • Allowed a Medical Review Officer (MRO) to recommend the collection of an oral fluid specimen in certain situations, as permitted by agency policy

This week, the Office of Management and Budget (OMB) approved the revised Federal Custody and Control Form (CCF). This approval essentially links the forthcoming testing changes to the required paperwork that will accompany the testing specimens. HHS published a Q&A document to help clarify a number of the changes.

While the impact of these revised regulations is somewhat complex, here are a few key insights that you should be aware of at this time:

1. These changes only apply to Federal employee testing. If your company performs oral fluid, hair, instant, or non-DOT urine drug testing, these changes do not apply to your program.

**Update** On Friday, November 10, 2017, the U.S. Department of Transportation (DOT) amended its regulations to add hydrocodone, hydromorphone, oxymorphone, and oxycodone, four commonly-abused opioids; add methylenedioxyamphetamine as an initial test analyte; and remove methylenedioxyethylamphetamine as a confirmatory test analyte. This change harmonizes DOT regulations with the HHS guidelines published earlier this year. The Final Rule published in the Federal Register on Monday, November 13, and the new testing standards will go into effect on January 1, 2018. Read the full text of the Final Rule.

2. At this time, you should not order new paper CCF forms. The new Federal form was approved earlier this week—on August 8, 2017. As such, the printing of new forms has not yet begun. The Federal forms you have on hand today are still valid and can be used without issue for another 10 months—until June 30, 2018.

**Update** On Tuesday, August 15, 2017, the Department of Transportation (DOT) published a notice in response to the HHS release from August 8, 2017. In this notice, they state that because the DOT’s final rule on synthetic opiates has yet to be issued, “…employers and their service agents are to continue using the ‘old’ CCF until further notice from DOT’s Office of Drug and Alcohol Policy and Compliance.”

3. The anticipated go-live date for the testing changes detailed in the bullet points above is October 1, 2017. This week’s announcement only pertains to Federal CCF forms, and was essentially published to give laboratories and other service providers the ability to cease production of the legacy form and to transition production to the new form.

4. There has never been a better time to switch to eCCF. You have better things to do than keeping tabs on changing form and panel regulations, ensuring you’re using the correct form at the proper time, and dealing with the expense and hassles of shipping and storing all of this paperwork. Our electronic CCF (eCCF) process helps bear the regulatory and administrative burden for you— the new, online form is scheduled to go live in our system on October 1. There’s no cost to use it, it’s available today for all specimen types and testing reasons, and it’s simple to use. In the time it’s taken you to read this article, you could have signed up and gotten started.

As your partner in drug testing and workplace safety, we are aware of the changes and are working diligently on your behalf to ready our laboratories, systems, and personnel. We are committed helping create a smooth and seamless transition as we collectively adapt to the regulatory obligations to which we’re bound.

As we do all of this, you should do four simple things:

  • Continue testing as usual. The effort at this point falls on the laboratory, not on you or your drug testing program. You do not need new forms at this time.
  • Get news and updates from the DOT via email by subscribing to the DOT notification system (list serve).
  • Subscribe to our newsletter to ensure you stay current with news and updates on this and other topics.
  • Join the thousands of customers of all sizes and in all industries who have moved away from paper-based drug testing documentation and who are now processing millions of eCCFs each year

For more information about drug testing, visit our website or contact us online.

By the Numbers: Random Drug Testing Data

September 22, 2017Drug Testing

Companies drug test their applicants and employees at a variety of times, for a variety of reasons, using a variety of specimen types. The federally-mandated, safety-sensitive sector follows regulatory drug testing guidance, and in doing so establishes a model that is frequently followed by U.S. companies, who elect to perform drug testing because they see […]

Read the full article →

Top 7 trends at SAPAA

August 30, 2017Drug Testing

Hundreds of drug and alcohol testing industry professionals met in Las Vegas for the annual Substance Abuse Program Administrators Association (SAPAA) conference last week. As a platinum sponsor, we are proud to support a group whose mission is to establish, promote, and communicate the highest standards of quality, integrity, and professionalism in the administration of workplace […]

Read the full article →

What to Expect at a Drug Test Collection

July 21, 2017Drug Testing

Your shirt is pressed, your haircut is fresh, and you’ve rehearsed all possible scenarios for this interview as your hopeful journey for a new employment opportunity begins. Thankfully, the state of today’s economy may work in your favor, according to the U.S. Bureau of Labor Statistics, more than 90% of states are currently experiencing stable […]

Read the full article →

Ask the Experts: Drug testing cutoffs

July 18, 2017Drug Testing

Question: Can you explain cutoff levels for laboratory-based drug testing? In workplace drug testing, the industry standard process involves two-tiered testing – an initial screen on one portion of the specimen, followed by a confirmatory test on a second portion of the original specimen. The initial test is designed to separate negative specimens from further […]

Read the full article →

2017 National Prescription Drug Take-Back Day

April 14, 2017News

An ambulance blazes by a sea of idling cars in the midst of evening rush-hour. Weaving through traffic, the EMT’s singular goal is to arrive at the emergency room as quickly as possible. The passenger is a victim of accidental prescription drug poisoning. This scenario plays out daily in cities across the country. In fact, […]

Read the full article →

See the eCCF Difference for Yourself

April 7, 2017Drug Testing

If a picture is worth a thousand words, imagine how much a 3-minute video can say about electronic custody and control forms (eCCFs). Since we launched eCCF in January, clients have been asking for more information about how it works and the advantages it can bring to their regulated and non-regulated drug testing programs. The […]

Read the full article →

Drug Test Collections When You Need Them

March 31, 2017Collections

Every accident is different, as are the causes behind them. And while the environment, human error, and equipment failures are frequent causes, all too often we also see the use of alcohol and drugs playing an influential role. According to the Quest Diagnostics Drug Testing Index™, the percentage of employees in the combined U.S. workforce […]

Read the full article →

By the Numbers: Going Green with eCCF

March 1, 2017By the Numbers

Our By the Numbers blog series takes a closer look at the numbers, facts, data, and outputs that impact workplace drug testing programs. In this post, we examine the environmental impact of moving from paper-based custody and control forms (CCF) to electronic custody and control forms (eCCF). Paper-based CCFs have been a mainstay of the drug testing […]

Read the full article →